Todd M. Cooper

Seattle Children's Hospital

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma”.

Integration of Genomic Sequencing Drives Therapeutic Targeting of PDGFRA in T-Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2562

N/A

0.346DataRank · unranked

6 citations

Boris Dimitrov, Beth Apsel Winger, Angélica Sandoval‐Pérez, Amith Vikram Rangarajan, Nicole Ocasio-Martinez +35 more

Vincristine Sulfate Liposome Injection With Combination Chemotherapy for Children, Adolescents, and Young Adults With Relapsed Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia and Lymphoma Consortium Trial

Pediatric Blood & Cancer(2025)10.1002/pbc.31584

N/A

0.165DataRank · unranked

2 citations

Eric S. Schafer, Yueh‐Yun Chi, Jemily Malvar, Kenneth Heym, Andrew E. Place +22 more

Molecular risk markers define risk of relapse in myeloid leukemia of Down syndrome beyond measurable residual disease

Blood Advances(2025)10.1182/bloodadvances.2025017837

N/A

0.104DataRank · unranked

1 citations

Anupam Verma, Shelton A. Viola, Todd A. Alonzo, Yicheng Wang, Lisa Eidenschink Brodersen +15 more

Aberrantly low STAT3 and STAT5 responses are associated with poor outcome and an inflammatory gene expression signature in pediatric acute myeloid leukemia

Clinical & Translational Oncology(2021)10.1007/s12094-021-02621-w

N/A

0DataRank · unranked

8 citations

Tsz‐Kwong Man, Robert B. Gerbing, Rhonda E. Ries, Alexandra M. Stevens, Y.-C. Wang +7 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.10018

N/A

0DataRank · unranked

0 citations

Xiaowei Liu, Charles G. Minard, Sarah Menig, Joel M. Reid, Emasenyie Isikwei +6 more

Integrated stem cell signature and cytomolecular risk determination in pediatric acute myeloid leukemia

Nature Communications(2022)10.1038/s41467-022-33244-6

N/A

0DataRank · unranked

49 citations

Jenny L. Smith, Jason E. Farrar, Yi‐Cheng Wang, Masayuki Umeda, Rhonda E. Ries +21 more

Temsirolimus combined with cyclophosphamide and etoposide for pediatric patients with relapsed/refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium trial (TACL 2014-001)

Haematologica(2022)10.3324/haematol.2021.279520

N/A

0DataRank · unranked

20 citations

Lewis B. Silverman, James A. Whitlock, Richard Sposto, Joseph P. Loftus, Eric S. Schafer +13 more

Comprehensive molecular and clinical characterization of NUP98 fusions in pediatric acute myeloid leukemia

Haematologica(2023)10.3324/haematol.2022.281653

N/A

0DataRank · unranked

76 citations

Jenny L. Smith, Lauren Harmon, Rhonda E. Ries, Yi-Cheng J. Wang, Todd A. Alonzo +32 more

Children's Oncology Group's 2023 blueprint for research: Myeloid neoplasms

Pediatric Blood & Cancer(2023)10.1002/pbc.30584

N/A

0DataRank · unranked

26 citations

Todd A. Alonzo, Sarah K. Tasian, Matthew A. Kutny, Johann Hitzler, Jessica A. Pollard +4 more

Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712

Pediatric Blood & Cancer(2023)10.1002/pbc.30672

N/A

0DataRank · unranked

3 citations

Xiaowei Liu, Charles G. Minard, Emasenyie Isikwei, Joel M. Reid, Terzah M. Horton +4 more

CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children’s Oncology Group

Haematologica(2024)10.3324/haematol.2023.283757

N/A

0DataRank · unranked

10 citations

Chad A. Hudson, Todd A. Alonzo, Robert B. Gerbing, Laura Pardo, Amanda R. Leonti +18 more

Diagnosis and management of AML in pediatric patients: consensus recommendations from an international expert panel

Blood(2025)10.1182/blood.2024027904

N/A

0DataRank · unranked

14 citations

Sarah K. Tasian, Richard Aplenc, Lisa Eidenschink Brodersen, Barbara Buldini, Barbara De Moerloose +20 more

Cytarabine Pharmacogenomics and Outcomes Among Children and Young Adults With Acute Myeloid Leukemia

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.16296

N/A

0DataRank · unranked

1 citations

Vivek M. Shastri, Deedra Nicolet, Krzysztof Mrózek, Christopher J. Walker, William Blum +19 more

The genomic landscape of juvenile myelomonocytic leukemia

UNC Libraries(2020)10.17615/mrye-5404

N/A

0DataRank · unranked

0 citations

Ariel Yu, Chip Stewart, Joseph F. Costello, Kimo C. Stine, Elliot Stieglitz +27 more

Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid Malignancies

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.12.003

N/A

0DataRank · unranked

0 citations

Ted Gooley, Monica S. Thakar, Scott N. Furlan, Corinne Summers, Danielle Kirkey +11 more

CEBPA-bZip mutations are associated with favorable prognosis in de novo AML: a report from the Children’s Oncology Group

Blood(2021)10.1182/blood.2020009652

N/A

0DataRank · unranked

122 citations

Adam J. Lamble, Yi‐Cheng Wang, Robert B. Gerbing, Rhonda E. Ries, Michael R. Loken +13 more

CBFB-MYH11 fusion transcripts distinguish acute myeloid leukemias with distinct molecular landscapes and outcomes

Blood Advances(2021)10.1182/bloodadvances.2021004965

N/A

0DataRank · unranked

11 citations

Jenny L. Smith, Yi‐Cheng Wang, Kassra Taghizadeh, Amanda R. Leonti, Rhonda E. Ries +19 more